Can Autoimmune Disease Be Cured? Scientists Say We May Be Close

The monumental effort to find methods for healing auto-immune diseases may be taking a turn in the right direction.
Can Autoimmune Disease Be Cured? Scientists Say We May Be Close
(AshTproductions/Shutterstock)
Ayla Roberts
2/10/2024
Updated:
2/26/2024
0:00
Researchers have endeavored to tame the cells responsible for autoimmune disorders for decades. Now, scientists believe that life-changing research, with the potential to cure autoimmune diseases, is on the horizon at last.

The History of Searching for a Cure

In 2001, immunologist Pere Santamaria, came up with an innovative idea while conducting diabetes research on mice. He used iron oxide nanoparticles to track immune cells, then developed an idea to use them as a therapy to target, neutralize, and even kill the cells responsible for causing diabetes. A January article published in the journal Nature notes that Mr. Santamaria’s study with mice found “both the control and the experimental nanoparticles reversed diabetes symptoms.”

Now, over twenty years later, Mr. Santamaria’s revolutionary therapy will soon be tested on humans for the first time.

For more than 50 years, researchers have tackled the monumental task of trying to create targeted therapies for autoimmune disorders. Currently, a few different strategies are being implemented to achieve it. Some scientists aim to restore the immune system’s ability to ignore cells that belong in the body and attack the ones that don’t. Other researchers are attempting to selectively kill the problematic cells, while still others are introducing engineered immune cells into the body to target and suppress unwanted cells.

All of these methods have the potential to revolutionize the way autoimmune diseases are treated. Most current therapies suppress the entire immune system, rather than specifically targeting the cells causing the autoimmune response. While current therapies can alleviate symptoms, they often come with a higher risk of infections and cancers.

“This research is indeed promising for the future of autoimmune disease treatment. We need to move away from broad immune suppression to targeted immune modulation for more effective and safer treatment of autoimmune disease,” Dr. Menka Gupta told The Epoch Times in an email. Dr. Gupta is a functional medicine doctor specializing in the treatment of autoimmune diseases.

How Do Autoimmune Diseases Affect the Body?

Autoimmune diseases are a result of immune system malfunction. Normal immune systems can tell the difference between healthy cells and foreign ones. However, if the immune system is impaired, it mistakenly attacks healthy cells, tissues, or organs. This harmful mechanism manifests in different ways depending on the autoimmune disease. For example, in multiple sclerosis, the body attacks the myelin sheath surrounding nerves, while in celiac disease, gluten triggers the immune system to attack the lining of the intestine.

“Autoimmune diseases are the immune system’s inability to distinguish between foreign and self-antigens, which leads to an attack on the body’s own tissues. If proteins in a pathogen (like a virus or bacteria) closely resemble the body’s own proteins, when the immune system targets these pathogen proteins, it can mistakenly attack the body’s similar proteins, potentially triggering an autoimmune response,” Dr. Gupta explains.

Autoimmune diseases can be serious and even life-threatening. According to Dr, Gupta, “They can cause severe organ damage, significant systemic inflammation, or are compounded by infections due to compromised immunity.”

There are more than 80 known autoimmune diseases and while many treatment options are available to help manage symptoms, most of them have no known cure. Autoimmune disorders can be extremely debilitating and many people require lifelong treatment to ease symptoms.
“Autoimmune diseases are typically treated with immunosuppressants, anti-inflammatory drugs, and biological agents that modulate the immune system,” explains Dr Gupta.

Exploring Potential Pathways to Tolerance

Deciding which approach to curing autoimmune disease is best for humans is one of the main challenges scientists are facing. Researchers are exploring ways to restore the body’s tolerance to specific antigens in the hope that autoimmune diseases can be treated without compromising the immune system’s ability to fight off real threats.
Previous research efforts have attempted to desensitize the immune system by administering large amounts of the problematic antigen, but this method had varying levels of success. The problem is further complicated by the fact that some conditions cause the body’s immune system to react to multiple antigens, not just one.

Mr. Santamaria believes he has found a mechanism that can function as a type of “master switch,” effectively turning off the autoimmune response while leaving the immune system uncompromised. During his experiments, Mr. Santamaria was able to direct tagged antigen molecules to the liver, where rogue autoimmune cells can be deleted or deactivated.

Researchers are exploring three main pathways to tolerance:

1. By leveraging the power of the liver—The liver is a key component of immune tolerance due to its role in filtering foreign antigens. Multiple scientists have conducted studies in which they have directed antigens to the liver of mice and symptoms of autoimmune disease were subsequently reversed.
2. Through nanoparticle presenters—In this method, nanoparticles carry antigen and immune particles, allowing them to create new T-cells which encourage tolerance to develop.
3. Through killing B-cells—The B-cells associated with autoimmune disease produce harmful autoantibodies. Using reengineered T-cells, scientists are able to delete the dangerous B-cells completely.
“The main treatment so far has been suppressing the immune system or symptomatic relief. Addressing the underlying cause has been challenging under conventional treatment modalities. There is also a great degree of variability in disease manifestation. Complexity of the immune system and multifactorial causes (genetic, environmental, microbial) add to the challenge,” Dr. Gupta explains.

Hope for the Future

While Mr. Santamaria’s strategy has yet to be tested on human subjects, the first trial is set to begin this year. Other clinical trials on humans are poised to begin this year in additional laboratories, as well.

There is still much to learn. Cellular therapies carry several challenges, including high costs and possible side effects. It can be difficult to determine the right dosage of cells, considering these cells begin to replicate within the body immediately upon introduction and cannot easily be removed.

Still, scientists are closer than they have ever been to finding a cure for autoimmune disease and the initiation of human clinical trials this year will hopefully bridge the gap between possibility and reality.

Ayla Roberts is a registered nurse and freelance writer. She holds both a bachelor's and master's degree in nursing and has worked in a variety of clinical and academic roles.
twitter
Related Topics